Search Results 811-820 of 16825 for Linaclotide

  1. Chronic lymphocytic leukemia - Doctors and departments - Mayo Clinic

    Learn about this cancer that forms in white blood cells called lymphocytes. Treatments include chemotherapy, targeted therapy and immunotherapy.

  2. Publications - Lihong Bu, M.D., Ph.D. - Mayo Clinic

    Nasr SH, Caza TN, Larsen CP, Storey A, Buglioni A, Alexander MP, Fidler ME, Bu L, Cornell LD, Fervenza FC, Sethi S. Dual-antigen membranous nephropathy.

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

    The OLE period is intended to allow each patient at least 1 year of treatment with open-label benralizumab 30 mg administered SC every 4th week (earlier ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. Oncology (Medical) - Clinical trials

    The purpose of this study is to study the handling of ovarian tissue, cryopreservation technology, and oocyte maturation for female pediatric cancer ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  9. Dysfunction of Mesenchymal Stem/Stromal Cells Induced by Obesity - Mayo Clinic

    The purpose of this study is to determine how human obesity engages epigenetic mechanisms that impair human mesenchymal stem/stromal cells (MSC) mitochondrial ...

  10. Follicular Lymphoma Clinical Trials - Mayo Clinic Research

    This randomized phase III trial studies rituximab and yttrium Y-90 ibritumomab tiuxetan to see how well they work compared to rituximab alone in treating ...